X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Administration’s Special 301 Report highlights deteriorating global environment for biopharmaceutical innovation

By Jay Taylor  |    May 23, 2017
In the latest publication of its annual Special 301 Report, the Office of the U.S. Trade Representative (USTR) brings renewed attention to intellectual property (IP) and market access challenges...   Read More

Trading fair means upholding the law: A focus on patents

By Jay Taylor  |    April 18, 2017
Patents are the linchpin of innovation. In the United States and other countries around the world, they provide temporary protection for new inventions. A fair, stable and predictable patent...   Read More

Enforcing unmet trade obligations protects U.S. innovation

By Jay Taylor  |    April 11, 2017
The United States leads the world in medical innovation, helping patients across the globe access the latest life-saving treatments and cures. Trade agreements with other nations serve as the...   Read More

Time to enforce the rules that protect American ideas, brands and inventions

By Chris Moore  |    March 1, 2016
Earlier today, PhRMA joined organizations representing every sector of America’s knowledge economy at a public hearing in Washington that will inform the federal government’s annual “Special 301”...   Read More

Canada’s chance to reform its approach to innovation

By Jay Taylor  |    February 5, 2016
Intellectual property drives and sustains research, development and delivery of valuable new treatments and cures for patients who need them around the world. America’s world-leading...   Read More

U.S. Trade Representative Continues the Vital IP Dialogue

By Jay Taylor  |    February 24, 2015
Understanding how intrinsic intellectual property (IP) is to the United States economy (innovative industries support more than a quarter of all jobs in the U.S.), the Office of the U.S. Trade...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates